Genetic characterization of the 534DPPR motif of the yeast plasma membrane H+-ATPase  by Portillo, Francisco
Genetic characterization of the 534DPPR motif of the yeast plasma
membrane H-ATPase
Francisco Portillo *
Instituto de Investigaciones Biome¤dicas ‘Alberto Sols’ (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain
Received 24 March 2000; received in revised form 16 May 2000; accepted 29 May 2000
Abstract
The highly conserved motif 534DPPR of Saccharomyces cerevisiae H-ATPase, located in the putative ATP binding site,
has been mutagenized and the resulting 23 mutant genes conditionally expressed in secretory vesicles. Fourteen mutant
ATPases (D534A, D534V, D534L, D534N, D534G, D534T, P535A, P535V, P535L, P535G, P535T, P535E, P535K and
R537T) failed to reach the secretory vesicles. Of these mutants, nine (D534N, D534T, P535A, P535V, P535L, P535G, P535T,
P535E and P535K) were not detected in total cellular membranes, and five (D534A, D534V, D534G, D534L and R537T)
were retained at the endoplasmic reticulum and exhibited a dominant lethal phenotype. The remaining mutants (D534E,
R537A, R537V, R537L, R537N, R537G, R537E, R537K and R537H) reached the secretory vesicles at levels similar to that
of the wild type. Of these, six (R537A, R537V, R537L, R537N, R537G, and R537E) showed severely decreased ATPase
activity compared to the wild type enzyme, and three (D534E, R537K and R537H) rendered an enzyme with an altered Km
for ATP. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: H-ATPase; Plasma membrane; Site-directed mutagenesis ; Saccharomyces cerevisiae
1. Introduction
The yeast plasma membrane H-ATPase from
Saccharomyces cerevisiae is an electrogenic proton
pump essential for nutrient uptake and intracellular
pH regulation [1,2]. The ATPase belongs to the P-
type ion translocating ATPase family, which forms
an acyl-phosphate intermediate during catalysis and
is sensitive to vanadate [3].
The genes encoding members of the P-type ATP-
ase family from bacterial, fungal, plant and animal
cells have been cloned and sequenced. Hydropathy
analysis has revealed a common topology for the
P-ATPases [4,5], with two hydrophilic domains and
10 transmembrane segments. This model is in agree-
ment with recent data from cryoelectron microscopy
of frozen^hydrated crystals of sarcoplasmic reticu-
lum Ca2-ATPase and Neurospora crassa H-ATP-
ase [6,7]. Comparison of P-ATPase amino acid se-
quences showed that they share several highly
conserved motifs, including consensus sequences for
ATP binding and phosphorylation [8^12]. In yeast
H-ATPase, sequence analysis suggests that the pu-
tative nucleotide binding site is located in the major
hydrophilic domain of the enzyme at positions 430^
0005-2736 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
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680 [13]. Moreover, results based on chemical label-
ing experiments of the major hydrophilic domain of
the sarcoplasmic reticulum Ca2-ATPase and yeast
H-ATPase suggest the involvement of this region
of the enzyme in ATP binding [14,15].
In previous studies, we isolated a mutations at
Pro-536 of the yeast H-ATPase that acts as an al-
lele-nonspeci¢c suppressor, since it was able to sup-
press mutations located in di¡erent regions of the
enzyme [16,17]. Genetic characterization of site-di-
rected mutants at this residue suggest that Pro-536
is an important determinant in enzyme biogenesis
[18]. Pro-536 is located within the sequence motif
534DPPR, which is a likely loop in the structure of
the enzyme and is believed to form part of the ATP
binding site [13]. This ¢nding prompted us to further
characterize the e¡ect of 534DPPR substitutions on
enzyme function. In this report, we show that muta-
tion at Asp-534 and Arg-537 alter the apparent Km
of the enzyme for ATP, and that Pro-535 is impor-
tant for the biosynthesis and/or stability of the pro-
tein.
2. Materials and methods
2.1. Yeast strains and growth media
Saccharomyces cerevisiae strain SY4 is GAL
MATa ura3 leu2 his4 sec6 pma1 : :YIpGAL-PMA1
and was used to express the ATPase in secretory
vesicles [19]. Strain XZ611 is Gal MATa ura3 leu2
trp1 [20] and was used in immuno£uorescence experi-
ments. Synthetic media with 2% dextrose (SD), 2%
ra⁄nose (SR) or 2% galactose (SG) and the appro-
priate requirements were used [21]. Yeast cells were
transformed using the lithium acetate procedure [22].
To test the dominant lethality of the pma1 alleles,
transformants were transferred to SR medium and,
after growth, suspended in water at a cell density of
2U107 cell/ml, and 5 Wl was dropped on SG.
2.2. Site-directed mutagenesis
A 2.2-kb XbaI fragment of PMA1 subcloned into
M13mp19 [25] was subjected to oligonucleotide-di-
rected mutagenesis using the method of Taylor et
al. [26] with the Amersham mutagenesis system
(Amersham Corp.). All ATPase fragments subjected
to mutagenesis were sequenced by the dideoxy meth-
od [27]. Mutagenesis e⁄ciency ranged from 70 to
100%, and the only sequence changes observed
were those introduced by the mutagenic oligonucleo-
tides. The ATPase gene fragments containing the
mutations were liberated from the M13mp19 replica-
tive form and inserted into a 5.0-kb HindIII frag-
ment containing the ATPase gene [23] inserted into
the pSB32 centromeric plasmid [24] in which the
2.2-kb XbaI fragment had previously been deleted.
2.3. Construction of hemagglutinin (HA)-tagged
pma1 alleles
The HA-tagged pma1 alleles used in this study
were generated by exchange of a 3.4-kb BstEII^Hin-
dIII fragment containing the desired mutation, with
the corresponding fragment in plasmid pFP302. The
plasmid pFP302 is a derivative of the URA3 single
copy plasmid YCp50 [24] and it carries a HA-tagged
wild type PMA1 under the control of the GAL1 pro-
moter [28].
2.4. Expression of ATPase in secretory vesicles
The 2.6-kb BamHI^HindIII fragments of PMA1
containing the substitutions were ligated into plasmid
pPMA1.2 [19] that had been digested with BamHI
and HindIII. After the fragments were moved into
plasmid pPMA1.2, a 3.77-kb SacI^HindIII fragment
containing the entire ATPase coding sequence was
cloned into vector YCp2HSE [19], placing the mu-
tant alleles under the control of a heat shock-induc-
ible promoter. The resulting plasmids were trans-
formed into strain SY4 [19]. This strain has the
chromosomal PMA1 gene under the control of the
GAL1 promoter and also carries the sec6-4 mutation
that blocks fusion of secretory vesicles with the plas-
ma membrane. For expression studies, transformed
SY4 cells were grown to mid-exponential phase
(OD660W0.5) on SG and shifted to SD for 3 h to
turn o¡ transcription of chromosomal PMA1, then
shifted to 37‡C for 2 h to turn on expression of the
plasmid-borne gene and block fusion of secretory
vesicles with plasma membrane. Secretory vesicles
were then isolated by di¡erential and sucrose gra-
dient centrifugation as described [29].
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2.5. Fluorescence microscopy
Strain XZ611, transformed with di¡erent pma1 al-
leles, was selected in SD medium. To induce
GAL1 : :pma1 gene expression, cells were cultured in
SR medium overnight at 30‡C, collected, resus-
pended in SG medium and cultured for 5 h at
30‡C. Cells were ¢xed and stained for immuno£uor-
escence as described [30]. Localization of HA-tagged
Pma1 was determined by immuno£uorescence using
a rhodamine-conjugated anti-HA antibody (Boehr-
inger-Mannheim, Mannheim, Germany).
2.6. Biochemical methods
Immunoquanti¢cation of the ATPase was per-
formed as described [31] using a⁄nity-puri¢ed rabbit
polyclonal antibody against yeast ATPase [32]. ATP-
ase activity was assayed at pH 6.5 with 5 mM ATP
[33]. H pumping into secretory vesicles was moni-
tored by £uorescence quenching of acridine orange
[19]. For the determination of Km values, the ATP
concentration was varied from 0.2 to 6 mM and the
concentration of free Mg2 was 1 mM. To determine
Ki values, the concentration of orthovanadate and
erythromycin B was varied from 0.5 to 20 WM. Pro-
tein concentration was determined by the Bradford
method [34] with the Bio-Rad Protein Assay Reagent
and bovine IgG as standard. Total membrane pro-
teins were separated by 8% SDS^PAGE using the
Laemmli system [35]. Western blot with second anti-
body conjugated to alkaline phosphatase (Bio-Rad)
was as described [36].
3. Results
The aim of this study was to explore the structure^
function relationships in the region surrounding Pro-
536. Amino acids subjected to site-directed mutagen-
esis were selected after a comparative study of the
sequence from 22 representative P-type ATPases dif-
fering in cation speci¢city and evolutionary origin.
There is a motif of high similarity from Asp-534
through Arg-537; upstream of Asp-534 and down-
stream of Arg-537 the degree of conservation de-
creases (Fig. 1). Within this motif Asp-534 is invar-
iant and Arg-537 is nearly invariant, Lys replaces the
latter in heavy metal pumps. Pro-535 is conserved
among H-, Na-, NaK-, HK-, Ca2- and
Mg2-ATPases; it is replaced by di¡erent amino
acids (Ser, Glu, Val, Thr, Ala, and Ile) in heavy
metal pumps and Escherichia coli K-ATPase. Based
on the alignment of Fig. 1, we carried out site-di-
rected mutagenesis of Asp-534, Pro-535 and Arg-
537. Each of the above-mentioned amino acids was
replaced with residues of di¡erent size and charge
(Table 1).
3.1. Expression of mutant ATPases in secretory
vesicles
Because some mutations could be lethal
[20,28,37,38], a transient expression system [19] was
used to characterize the e¡ect of the mutation on
Fig. 1. Alignment of the 534DPPR region in P-ATPases. Amino
acid sequences were aligned using the Pileup program of the
University of Wisconsin Genetic Computer Group. The en-
zymes were grouped depending on cation speci¢city. The
EMBL database accession numbers from top to bottom are:
P05030, P20649, P54210, P13587, P05023, P20648, P13586,
O74296, Q42883, P20647, P38929, P20020, O81108, P38360,
P38995, P05425, Q04656, P35670, Q53649, U78967, P36640 and
P03960.
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enzyme function. The mutant genes were placed
under the control of a heat shock-inducible promoter
in the plasmid YCp2HSE [19]. Plasmid YCp2HSE
containing the mutant genes was transformed into
strain SY4 [19]. This strain has the chromosomal
PMA1 gene under the control of the GAL promoter
and also carries the temperature-sensitive sec6-4 mu-
tation that blocks fusion of secretory vesicles with
the plasma membrane. Thus, when cells were incu-
bated in galactose medium at 23‡C, only the chro-
mosomal wild type ATPase was produced, and when
cells were transferred to glucose medium at 37‡C,
wild type ATPase expression was repressed and mu-
tant ATPase was expressed. Since strain SY4 carries
a temperature-sensitive sec6-4 allele, the shift to 37‡C
also led to accumulation of the newly synthesized
mutant ATPase in secretory vesicles. Secretory
vesicles were puri¢ed by di¡erential and sucrose gra-
dient centrifugation [29] for analysis of the mutant
ATPases; Table 1 summarizes the behavior of the
Table 1
Analysis of mutant ATPases accumulated in secretory vesicles
Allele expressed Amount of
ATPasea
ATPase activityb H transportc
Uncorrected (Wmol/min/mg) Corrected (%) Uncorrected (%Q/mg) Corrected (%)
Wild type 100 1.20 100 725 100
Noned 5 0.03 n.d.e n.d. n.d.
D534A 5 0.04 n.d. n.d. n.d.
D534V 8 0.03 n.d. n.d. n.d.
D534L 7 0.02 n.d. n.d. n.d.
D534N 5 0.03 n.d. n.d. n.d.
D534G 8 0.05 n.d. n.d. n.d.
D534T 5 0.05 n.d. n.d. n.d.
D534E 100 0.64 53 335 46
P535A 6 0.06 n.d. n.d. n.d.
P535V 6 0.05 n.d. n.d. n.d.
P535L 7 0.03 n.d. n.d. n.d.
P535G 5 0.02 n.d. n.d. n.d.
P535T 3 0.04 n.d. n.d. n.d.
P535E 8 0.02 n.d. n.d. n.d.
P535K 9 0.01 n.d. n.d. n.d.
R537A 95 0.20 17 b.s.f b.s.
R537V 90 0.24 22 b.s. b.s.
R537L 98 0.28 23 b.s. b.s.
R537N 80 0.16 16 b.s. b.s.
R537G 92 0.23 20 b.s. b.s.
R537T 7 0.04 n.d. n.d. n.d.
R537E 75 0.16 10 b.s. b.s.
R537K 80 0.58 60 320 55
R537H 105 0.60 47 330 43
aQuanti¢ed by immunoassay. The value for the wild type was considered 100%.
bATPase activity was assayed at pH 6.5 with 5 mM ATP. The speci¢c activity of each secretory vesicle preparation was measured as
the di¡erence between hydrolysis in the absence and presence of 250 WM orthovanadate. Values are the average of two independent
experiments di¡ering less than 15%. Each mutant value was corrected for the relative amount of mutant protein in the secretory
vesicle preparation.
cFluorescence quenching of acridine orange was used to monitor pumping of protons into secretory vesicles. Similar values (within
15%) were obtained with two di¡erent secretory vesicle preparations independently isolated. Each mutant value was corrected for the
relative amount of mutant protein in the secretory vesicle preparation.
dSecretory vesicles were isolated from SY4 transformed with the vector YCp2HSE carrying no PMA1 gene.
en.d. : not determined.
f b.s. : ATP-dependent £uorescent quenching was below the limits of sensitivity of the assay (6 20% of the wild type rate).
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mutant enzymes. The expression levels of D534E,
R537A, R537V, R537L, R537N, R537G, R537E,
R537K and R537H were similar to the wild type
control. All remaining mutant enzymes (D534A,
D534V, D534L, D534N, D534G, D534T, P535A,
P535V, P535L, P535G, P535T, P535E, P535K and
R537T) failed to reach the secretory vesicles. In a
parallel experiment, total cell membranes were iso-
lated and analyzed by Western blot (Fig. 2). In
many cases, the mutant protein could be detected
at near-normal levels 60 min after the temperature
shift, but for nine mutants (D534N, D534T, P535A,
P535V, P535L, P535G, P535T, P535E and P535K)
no Pma1 protein could be detected in total cellular
membranes. In an alternative experiment cells carry-
ing HA-tagged versions of these mutant ATPase
genes under the control of the GAL1 promoter
were shifted from glucose- to galactose-containing
medium. Total cellular membranes were puri¢ed at
di¡erent times of induction (30 min, 1, 2, 3, 4 and 5 h)
and analyzed by Western blot using anti-HA anti-
body. None of the above-mentioned mutant proteins
could be detected (data not shown). These results
suggest that these mutations could a¡ect the synthe-
sis and/or the short-term stability of the enzyme;
these mutants were not studied further. Secretory
vesicle preparations were next assayed for their abil-
ity to hydrolyze ATP and analyzed for ATP-depen-
dent proton transport (Table 1). Three mutants
(D534E, R537K and R537H) had hydrolysis and
transport activities ranging from 47 to 60% and
from 43 to 55% when correction for the expression
level in the secretory vesicle preparation is consid-
ered. Six mutants showed signi¢cant reduction in ac-
tivity (R537A to 17%, R537V to 22%, R537L to
23%, R537N to 16%, R537G to 20% and R537E to
10%) and accordingly the proton pumping activities
were too low (6 20% of wild type) to give a meas-
urable signal in the quenching assay.
We next analyzed the kinetic properties of the
D534E, R537K and R537H mutant enzymes (Table
2). The apparent KM for ATP of the mutants di¡ered
only slightly of the wild type enzyme. Nevertheless,
the mutant enzymes were more resistant to erythro-
mycin B inhibition. Erythromycin B inhibits the ATP
hydrolysis catalyzed by the ATPase by binding to the
enzyme nucleotide binding site [39]. These results
thus suggest that mutations D534E, R537K and
R537H could disturb the ATP binding domain struc-
ture.
3.2. Subcellular location of the mutant ATPases
Because D534A, D534V, D534L, D534G and
R537T mutations prevent accumulation of Pma1p
into secretory vesicles although they accumulate in
Table 2
Kinetic characterization of Asp-534 and Arg-537 mutants
Mutation KM(ATP) (mM) Ki(vanadate) (WM) Ki(erythromycin B) (WM) pH optimum
Wild type 1.6 2.0 1.0 6.00
D534E 3.3 1.8 5.0 6.00
R537K 4.0 2.3 5.0 6.00
R537H 3.0 2.0 2.5 6.00
Values were determined as described in Section 2 and are the average of two independent experiments.
Fig. 2. Accumulation of wild type and mutant ATPases in total cellular membrane. Strains are recombinants carrying either the
PMA1 or mutant genes under the control of a heat shock-inducible promoter into plasmid YCp2HSE. Cells were grown in SG me-
dium and transferred to SD to turn o¡ expression of the chromosomal PMA1 gene, and then shifted to 38‡C for 60 min to induce ex-
pression of the pma1 alleles. Total plasma membrane was analyzed by immunoblot using a⁄nity-puri¢ed rabbit polyclonal antibody
against yeast ATPase.
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total cellular membranes, we next studied the loca-
tion of the mutant ATPases. The HA-tagged genes
were placed under the control of the GAL1 promoter
in a centromeric plasmid and used to transform a
wild type strain (XZ611). The location of the mutant
HA-tagged proteins was studied in galactose-cultured
cells by immuno£uorescent staining of mutant
Pma1p with the anti-HA monoclonal antibody. In
D534E, R537A, R537V, R537L, R537N, R537G,
R537E, R537K and R537H, the anti-HA antibody
decorated the cell periphery (not shown); this was
also the case for the wild type control (Fig. 3). In
contrast, in D534A, D534V, D534L, D534G and
R537T, the HA-tagged mutant ATPase appeared to
accumulate in cytoplasmic structures. Such prolifer-
Fig. 3. Accumulation of the HA-tagged mutant protein in cyto-
plasmic structures. The transformants carried either the HA-
tagged PMA1 or HA-tagged pma1 genes under the control of
the GAL1 promoter. After galactose induction, cells were
stained for the nucleus (DAPI) or immunodecorated for the
HA-tagged Pma1p using a rhodamine-conjugated anti-HA anti-
body (anti HA).
Fig. 4. Drop test for growth of yeast strains expressing mutant
alleles of PMA1. Strains are recombinants, carrying the PMA1
wild type allele or the indicated pma1 gene under the control of
the galactose-inducible promoter. The test was performed as in-
dicated in Section 2. Plates were photographed after 36 h at
30‡C.
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ation of intracellular structures has been reported in
cells expressing dominant lethal Pma1 proteins
[20,28,38]. It was therefore of interest to determine
whether D534A, D534V, D534L, D534G and R537T
have, in fact, a dominant lethal phenotype. To this
end, cells expressing the HA-tagged mutant ATPase
genes under the control of the GAL1 promoter were
plated on galactose medium (Fig. 4). As predicted,
D534A, D534V, D534L, D534G and R537T failed to
grow on galactose medium, suggesting that they are
dominant lethal alleles. It is interesting to note that
R537A, R537V, R537L, R537N, R537G, and R537E
mutants, although not retained at the endoplasmic
reticulum and slightly active, exerted an inhibitory
e¡ect on cell growth, suggesting that they interfere
with the function of the wild type ATPase. Further
work is necessary to determine the speci¢c mecha-
nism a¡ected by these Arg-537 mutations.
4. Discussion
In this study, the role of amino acids Asp-534,
Pro-535 and Arg-537, predicted to be located in the
ATP binding domain of the yeast plasma membrane
H-ATPase, has been analyzed by site-directed mu-
tagenesis.
Replacement of Asp-534 by either nonpolar or
small polar residues resulted in enzymes severely im-
paired in their biogenesis ; only the conservative
change AspCGlu at this position resulted in an ac-
tive enzyme. Mutants at Arg-537 were close to nor-
mal in biogenesis in almost all cases, and had speci¢c
activities that ranged from 10% (R537E) to 60%
(R537K). Analysis of the kinetic properties of the
D534E, R537K and R537H mutant enzymes showed
that the apparent Kms of these enzymes were slightly
altered and that mutant enzymes were resistant to
the ATP binding inhibitor erythromycin B. Although
these data do not lead to de¢nitive conclusions, it
appears that the phenotype conferred by the
D534E, R537K and R537H mutations could be ex-
plained if we assume that these mutations disturb the
nucleotide binding site. The Asp-534 and Arg-537
residues are equivalent to the amino acids of the
sarcoplasmic reticulum Ca2-ATPase Asp-601 and
Arg-604, respectively, which have been shown to be
involved in nucleotide binding [40]. Further studies
involving chemical labeling experiments of the mu-
tant ATP binding domains overexpressed in E. coli
together with structural work (nuclear magnetic res-
onance, X-ray crystallography) will de¢nitively clar-
ify the role of the 534DPPR motif.
With respect to Pro-535, the fact that P535A,
P535V, P535L, P535G, P535T P535E or P535K
were not detected in total cellular membrane suggests
that this residue is important for the biosynthesis
and/or stability of the ATPase. The present data do
not allow us to determine whether these mutations
a¡ect the biosynthesis or the stability of the enzyme,
but comparison with published data for other PMA1
mutants, which exhibit the same phenotype [41], in-
dicates that it may be reasonable to consider that
Pro-535 mutations a¡ect the enzyme stability. In
the case of the sarcoplasmic reticulum Ca2-ATPase,
replacement of this residue (Pro-602) by leucine has
no noticeable e¡ect on ATPase biogenesis and activ-
ity [40]. Despite sequence conservation, mutations at
Pro-535 of the yeast H-ATPase appear to have a
much more deleterious e¡ect on the enzyme than do
equivalent changes in Ca2-ATPase. This dissimilar
behavior between PMA1 mutations and their coun-
terparts in other yeast and mammalian P-ATPases
has been observed with mutations at the phosphor-
ylation site [38]. Further data must be obtained to
understand the molecular basis for this striking dif-
ference.
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